SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001785530-23-000016
Filing Date
2023-05-11
Accepted
2023-05-11 07:05:12
Documents
14
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K howl-20230511.htm   iXBRL 8-K 36204
2 EX-99.1 a03312023ex991.htm EX-99.1 55780
6 werewolflogohorizontala.jpg GRAPHIC 277881
  Complete submission text file 0001785530-23-000016.txt   626669

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20230511.xsd EX-101.SCH 1946
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20230511_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20230511_pre.xml EX-101.PRE 13621
8 EXTRACTED XBRL INSTANCE DOCUMENT howl-20230511_htm.xml XML 12318
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40366 | Film No.: 23908761
SIC: 2834 Pharmaceutical Preparations